Veradermics Inc.

MANE

We are a dermatologist-founded, late clinical-stage biopharmaceutical company, or the Company, we, us, or our , focused on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. Our initial focus is developing better treatments for PHL, a condition affecting approximately 50 million men and 30 million women in th…

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$5.70B

EPS-$111.91

P/E–

P/FCF–

EV/EBITDA–

FCF Yield–

Div. Yield–

Net Debt/FCF–

Veradermics Inc. intrinsic value

52-Week Range

$37.03$143.85

Profitability & Returns

TTM as of 2026-06 · YoY vs prior year · ROIC = NOPAT / invested capital

Revenue

N/A

Net Income (FY)

-$70M

▼ -164.3% YoY

Op. Margin

–

ROIC

-2857706.50%

Cash Flow & Balance Sheet

FCF = operating cash flow + capex · Net debt = total debt − cash · Balance sheet from latest filing

FCF (FY)

-$72M

▼ -202.4% YoY

Op. Cash Flow (FY)

-$72M

▼ -202.3% YoY

Net Debt

-$819M

Net Cash Position

Cash & Equiv.

$820M

Continue Research

Quality Scorecard

Is this a high-quality business?

Dividends

Payout safety and growth

Intrinsic Value

What is it worth?

Financials

Full income, cash flow, balance sheet

SourceComputed from the 10-Q filed 6 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 12 Aug 2026. How this is calculated.

Price from market data, last close as of 4 Nov 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.

Peers

Pharmaceutical Preparations · Pick stocks to compare with MANE

CompareIntrinsic value

NGNENeurogene Inc.

$27.58+3.41%10

MREOMereo BioPharma Group plc

$0.30+4.12%10

COYACoya Therapeutics Inc.

$3.08-0.96%10

PRLDPrelude Therapeutics Incorporated

$4.08+7.94%40

PLRXPliant Therapeutics Inc.

$0.85-1.07%10

AARDAardvark Therapeutics, Inc.

$1.26+2.44%10

ORMPOramed Pharmaceuticals Inc.

$4.13+3.25%35

NTHINeonC Technologies Holdings

$3.17+3.26%10

Held by ETFs

MANE is in 29 US ETFs. The largest of them, with MANE's weight in each:

Spot a number that looks wrong? Check it in MANE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MANE

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.